Dr. Andre Boulet reports

DEVONIAN HEALTH GROUP PROVIDES UPDATE ON ITS PLANNED NYSE AMERICAN LISTING

Devonian Health Group Inc. today provided an update on its proposed listing on the NYSE American in connection with its initial public offering in the United States, as initially announced on July 27, 2026, and subsequently updated in the company's press releases dated Aug. 18, 2026, and Sept. 11, 2026.

The company remains committed to completing this initiative. Devonian continues to actively work with ThinkEquity on the preparations and necessary steps to complete the offering and the listing of its common shares and warrants on the NYSE American under the symbols DHGR and DHGR WS, respectively.

The company will provide an update, by way of a press release, of the revised anticipated date for the commencement of trading of its securities on the NYSE American and the expected closing date of the offering, both of which remain undetermined at this time.

The offering and the proposed listing on the NYSE American are subject to market conditions and the receipt of required regulatory approvals, including those of the NYSE American LLC and the TSX Venture Exchange. There can be no assurance that the offering will be completed or, if completed, as to its timing, size or final terms. The company remains listed on the TSX-V.

About Devonian Health Group Inc.

Devonian Health Group is a clinical stage pharmaceutical company specializing in the development of drugs for various auto-immune fibroinflammatory disease with novel therapeutic approaches to targeting unmet medical needs. Devonian's core strategy is to develop prescription drugs for the treatment of fibroinflammatory autoimmune diseases including but not limited to atopic dermatitis, radiodermatitis and ulcerative colitis.

Devonian Health Group was incorporated in 2015 and is headquartered in Quebec, Canada, where it owns a state-of-the-art extraction facility. Devonian is traded publicly on the TSX-V (TSX-V: GSD) and currently quoted on the OTCQB Venture Market (OTCQB: DVHGF).

We seek Safe Harbor.